77 related articles for article (PubMed ID: 8294998)
1. Antisense DNA delivery in vivo: liver targeting by receptor-mediated uptake.
Lu XM; Fischman AJ; Jyawook SL; Hendricks K; Tompkins RG; Yarmush ML
J Nucl Med; 1994 Feb; 35(2):269-75. PubMed ID: 8294998
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of hepatitis B virus replication by targeted pretreatment of complexed antisense DNA in vitro.
Nakazono K; Ito Y; Wu CH; Wu GY
Hepatology; 1996 Jun; 23(6):1297-303. PubMed ID: 8675142
[TBL] [Abstract][Full Text] [Related]
3. Targeted delivery of oligodeoxynucleotides to parenchymal liver cells in vivo.
Biessen EA; Vietsch H; Rump ET; Fluiter K; Kuiper J; Bijsterbosch MK; van Berkel TJ
Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):783-92. PubMed ID: 10359665
[TBL] [Abstract][Full Text] [Related]
4. Cell culture and xenograft-bearing animal studies of radiolabeled antisense DNA carrier nanoparticles with streptavidin as a linker.
Nakamura K; Wang Y; Liu X; Kubo A; Hnatowich DJ
J Nucl Med; 2007 Nov; 48(11):1845-52. PubMed ID: 17978353
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte-targeted in vivo gene expression by intravenous injection of plasmid DNA complexed with synthetic multi-functional gene delivery system.
Nishikawa M; Yamauchi M; Morimoto K; Ishida E; Takakura Y; Hashida M
Gene Ther; 2000 Apr; 7(7):548-55. PubMed ID: 10819569
[TBL] [Abstract][Full Text] [Related]
6. Targeted delivery of plasmid DNA to hepatocytes in vivo: optimization of the pharmacokinetics of plasmid DNA/galactosylated poly(L-lysine) complexes by controlling their physicochemical properties.
Nishikawa M; Takemura S; Takakura Y; Hashida M
J Pharmacol Exp Ther; 1998 Oct; 287(1):408-15. PubMed ID: 9765363
[TBL] [Abstract][Full Text] [Related]
7. PEGylation of poly(ethylene imine) affects stability of complexes with plasmid DNA under in vivo conditions in a dose-dependent manner after intravenous injection into mice.
Merdan T; Kunath K; Petersen H; Bakowsky U; Voigt KH; Kopecek J; Kissel T
Bioconjug Chem; 2005; 16(4):785-92. PubMed ID: 16029019
[TBL] [Abstract][Full Text] [Related]
8. Targeting specificity and pharmacokinetics of asialoorosomucoid, a specific ligand for asialglycoprotein receptor on hepatocyte.
Yang DY; Ouyang CH; Lu FG; Liu XW; Huang LQ
J Dig Dis; 2007 May; 8(2):89-95. PubMed ID: 17532821
[TBL] [Abstract][Full Text] [Related]
9. Tumor targeting and imaging of intraperitoneal tumors by use of antisense oligo-DNA complexed with dendrimers and/or avidin in mice.
Sato N; Kobayashi H; Saga T; Nakamoto Y; Ishimori T; Togashi K; Fujibayashi Y; Konishi J; Brechbiel MW
Clin Cancer Res; 2001 Nov; 7(11):3606-12. PubMed ID: 11705883
[TBL] [Abstract][Full Text] [Related]
10. 99mTc-neolactosylated human serum albumin for imaging the hepatic asialoglycoprotein receptor.
Jeong JM; Hong MK; Lee J; Son M; So Y; Lee DS; Chung JK; Lee MC
Bioconjug Chem; 2004; 15(4):850-5. PubMed ID: 15264873
[TBL] [Abstract][Full Text] [Related]
11. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides.
Hussain M; Shchepinov M; Sohail M; Benter IF; Hollins AJ; Southern EM; Akhtar S
J Control Release; 2004 Sep; 99(1):139-55. PubMed ID: 15342187
[TBL] [Abstract][Full Text] [Related]
12. Uptake kinetics of 99mTc-MAG3-antisense oligonucleotide to PCNA and effect on gene expression in vascular smooth muscle cells.
Zhang YR; Zhang YX; Cao W; Lan XL
J Nucl Med; 2005 Jun; 46(6):1052-8. PubMed ID: 15937319
[TBL] [Abstract][Full Text] [Related]
13. Reduction of liver tumor necrosis factor-alpha expression by targeting delivery of antisense oligonucleotides into Kupffer cells protects rats from fulminant hepatitis.
Dong L; Zuo L; Xia S; Gao S; Zhang C; Chen J; Zhang J
J Gene Med; 2009 Mar; 11(3):229-39. PubMed ID: 19189285
[TBL] [Abstract][Full Text] [Related]
14. Evidence of antisense tumor targeting in mice.
Nakamura K; Fan C; Liu G; Gupta S; He J; Dou S; Kubo A; Rusckowski M; Hnatowich DJ
Bioconjug Chem; 2004; 15(6):1475-80. PubMed ID: 15546217
[TBL] [Abstract][Full Text] [Related]
15. [Inhibition of HBV gene expression by antisense oligonucleotides using galactosylated poly (L-lysine) as a hepatotropic carrier].
Zhong S; Wen S; Zhang D
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Jun; 15(2):150-3. PubMed ID: 11436645
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive imaging of human telomerase reverse transcriptase (hTERT) messenger RNA with 99mTc-radiolabeled antisense probes in malignant tumors.
Liu M; Wang RF; Zhang CL; Yan P; Yu MM; Di LJ; Liu HJ; Guo FQ
J Nucl Med; 2007 Dec; 48(12):2028-36. PubMed ID: 18006621
[TBL] [Abstract][Full Text] [Related]
17. Receptor-mediated gene delivery and expression in vivo.
Wu GY; Wu CH
J Biol Chem; 1988 Oct; 263(29):14621-4. PubMed ID: 3049582
[TBL] [Abstract][Full Text] [Related]
18. Increased liver uptake of liposomes and improved targeting efficacy by labeling with asialofetuin in rodents.
Wu J; Liu P; Zhu JL; Maddukuri S; Zern MA
Hepatology; 1998 Mar; 27(3):772-8. PubMed ID: 9500706
[TBL] [Abstract][Full Text] [Related]
19. Simplified preparation via streptavidin of antisense oligomers/carriers nanoparticles showing improved cellular delivery in culture.
Wang Y; Nakamura K; Liu X; Kitamura N; Kubo A; Hnatowich DJ
Bioconjug Chem; 2007; 18(4):1338-43. PubMed ID: 17605463
[TBL] [Abstract][Full Text] [Related]
20. Receptor-mediated delivery of hepatitis B virus DNA and antisense oligodeoxynucleotides to avian liver cells.
Madon J; Blum HE
Hepatology; 1996 Sep; 24(3):474-81. PubMed ID: 8781310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
